Team:BostonU/Data

From 2012.igem.org

(Difference between revisions)
 
(105 intermediate revisions not shown)
Line 60: Line 60:
       font-size: 12pt;
       font-size: 12pt;
     }
     }
-
 
H7 {
H7 {
       font-family: Signika;
       font-family: Signika;
Line 67: Line 66:
       text-align: left;
       text-align: left;
       color: #000000;
       color: #000000;
-
       font-size: 11pt;
+
       font-size: 12pt;
     }
     }
 +
 +
H8 {
 +
      font-family: Signika;
 +
      text-transform: none;
 +
      text-decoration: none;
 +
      text-align: left;
 +
      color: #B22222;
 +
      font-size: 12pt;
 +
    }
 +
H9 {
 +
      font-family: Signika;
 +
      text-transform: none;
 +
      text-decoration: none;
 +
      text-align: left;
 +
      color: #B22222;
 +
      font-size: 14pt;
 +
    }
 +
 +
</style>
</style>
-
<link rel="stylesheet" type="text/css" href="http://static.tumblr.com/bepcnvc/YKnm67emn/team.css">
+
<link rel="stylesheet" type="text/css" href="http://static.tumblr.com/bepcnvc/zlPm6ibrh/team.css">
<link href='http://fonts.googleapis.com/css?family=Signika' rel='stylesheet' type='text/css'>
<link href='http://fonts.googleapis.com/css?family=Signika' rel='stylesheet' type='text/css'>
Line 80: Line 98:
<div id="bu-wellesley_wiki_content">
<div id="bu-wellesley_wiki_content">
-
<p  style="text-align:center;"><a href="https://2012.igem.org/Team:BostonU"><img src="https://static.igem.org/mediawiki/2012/5/5c/Achiev_header.png" width="800px"></a></p>
+
<p  style="text-align:center;"><a href="https://2012.igem.org/Team:BostonU"><img src="https://static.igem.org/mediawiki/2012/6/64/Achievements.png" width="800px"></a></p>
<ul id="nav">  
<ul id="nav">  
Line 92: Line 110:
<ul>  
<ul>  
<li><a href="https://2012.igem.org/Team:BostonU/Project_Overview">Project Overview and Abstract</a></li>  
<li><a href="https://2012.igem.org/Team:BostonU/Project_Overview">Project Overview and Abstract</a></li>  
-
<li><a href="https://2012.igem.org/Team:BostonU/Characterization">Introduction to Characterization</a></li>  
+
                        <li><a href="https://2012.igem.org/Team:BostonU/MoClo2">Introduction to MoClo</a></li>
 +
<li><a href="https://2012.igem.org/Team:BostonU/Characterization">Introduction to Characterization</a></li>
 +
                        <li><a href="https://2012.igem.org/Team:BostonU/DataSheet">Introduction to Data Sheets</a></li> 
<li><a href="https://2012.igem.org/Team:BostonU/Methodology ">Methodology Overview</a></li>  
<li><a href="https://2012.igem.org/Team:BostonU/Methodology ">Methodology Overview</a></li>  
<li><a href="https://2012.igem.org/Team:BostonU/Results ">Results Summary</a></li>  
<li><a href="https://2012.igem.org/Team:BostonU/Results ">Results Summary</a></li>  
Line 118: Line 138:
<li><a href="#">Considerations</a>  
<li><a href="#">Considerations</a>  
<ul>
<ul>
-
<li><a href="https://2012.igem.org/Team:BostonU/Advancement">Synthetic Biology Advancement</a></li>
+
<li><a href="https://2012.igem.org/Team:BostonU/NEGEM">New England iGEM Regional Meeting</a></li>
-
<li><a href="https://2012.igem.org/Team:BostonU/NEGEM">New England iGEM Regional Meeting</a></li>
+
<li><a href="https://2012.igem.org/Team:BostonU/Human Practices">Human Practices</a></li>  
<li><a href="https://2012.igem.org/Team:BostonU/Human Practices">Human Practices</a></li>  
<li><a href="https://2012.igem.org/Team:BostonU/Safety">Safety</a></li>
<li><a href="https://2012.igem.org/Team:BostonU/Safety">Safety</a></li>
Line 134: Line 153:
</ul>  
</ul>  
 +
 +
<div id="tracking_nav">
 +
JUMP TO...<br>
 +
<a href="#bu-wellesley_wiki_content">Top</a><br>
 +
<a href="#SeqData">Sequencing</a><br>
 +
<a href="#Character">Characterization</a><br><li>
 +
<a href="#BioBricksCha">BioBrick Characterization</a><br><li>
 +
<a href="#mmoR">New BioBrick Characterization</a><br>
 +
</div>
 +
 +
<p>
 +
<center>
 +
<img src="https://static.igem.org/mediawiki/2012/5/51/Databu.jpg" width="250px">&#8194;
 +
<img src="https://static.igem.org/mediawiki/2012/d/dc/Databu1.jpg" width="250px">&#8194;
 +
<img src="https://static.igem.org/mediawiki/2012/e/eb/Budata3.jpg" width="250px">
 +
</p></center>
<br>
<br>
<h4>Data Collected</h4>
<h4>Data Collected</h4>
<br>
<br>
-
<h3>Coming soon!</h3>
+
<div id="SeqData">
 +
<ul>
 +
<h9>Sequencing Data for Converted MoClo Parts</h9>
 +
<ul>
 +
<br>
 +
<h7><p dir="ltr">We sequenced all of our new MoClo parts to ensure the proper fusion sites were flanking the part sequence. Below is a list of all of the confirmed, sequenced parts, including our two BioBrick parts for <i>mmoR</i> and pMmoR.
 +
<br>
 +
</ul>
 +
</ul>
 +
<p>
 +
<center>
 +
<img src="https://static.igem.org/mediawiki/2012/d/d0/Seqdatabu.png" width="700">
 +
</p>
 +
</center>
 +
<ul>
 +
<br>
 +
<h7><p dir="ltr">After the wiki freezed we kept working on converting Biobricks to Level 0 MoClo parts and creating Level 2 Destination vectors. Below is a list of all of the confirmed, sequenced  new parts.
 +
<br>
 +
</ul>
 +
</ul>
 +
<br><br>
 +
<p>
 +
<center>
 +
<img src="https://static.igem.org/mediawiki/2012/9/94/Asdlkfjas%3Bdklfj.PNG" width="700">
 +
</p>
 +
</center>
 +
<br>
 +
<br>
 +
<div id="Character">
 +
<div id="BioBricksCha">
 +
<ul>
 +
<h9>Characterizing BioBrick Based Devices</h9>
 +
<br>
 +
<ul><h7><p dir="ltr">We began to work on our characterization workflow in September because we had originally planned to have MoClo Level 1 and Level 2 parts to test by then. Unfortunately, due to many technical challenges, we do not have a Level 1 or Level 2 part to test yet. In order to move forward with our characterization thrust, we decided to test devices that had been made in our lab using BioBricks so we could begin to learn how to characterize devices using flow cytometry.
 +
<br><br>
 +
One of those devices was an inverter under pBad (BBa_I13458-BBa_I13453) control. This inverter was built using the two-way BioBrick protocol and was submitted with the rest of our parts this year (<a href="http://partsregistry.org/Part:BBa_K783067">BBa_K783067</a>). As you can see below, this inverter functions as expected, where GFP increases with the addition of arabinose and thus the induction of the pBad promoter. The amount of RFP decreases as the amount of tetR increases, thus repressing the pTetR promoter.
 +
<br><br>
 +
This inverter uses the RBS BBa_B0032 to drive the tetR gene, while the other two ribosomal binding sites are BBa_B0034. Previous work in our lab showed the use of BBa_B0034 to drive the tetR gene resulted in poor function for the inverter. By changing the RBS, the function of this inverter was improved.
 +
<br>
 +
</ul></ul>
 +
<p>
 +
<center>
 +
<img src="https://static.igem.org/mediawiki/2012/e/ea/PTet_inverter.png" width="350">&#8194; &#8194;
 +
<img src="https://static.igem.org/mediawiki/2012/a/aa/B0034sbol.png" width="350">
 +
<br><br>
 +
<img src="https://static.igem.org/mediawiki/2012/8/86/Inverter_graph.png" width="390">&#8194;
 +
<img src="https://static.igem.org/mediawiki/2012/5/5a/B0034inv.png" width="390">
 +
</p>
 +
</center>
 +
<br><br>
 +
 
 +
<ul><ul><h7><p dir="ltr">We also tried to test the function of a cI based inverter, where cI and pCI replace tetR and pTetR. Unfortunately, those cells grew poorly and we were unable to complete our experiment. We believe cI may have some level of toxicity to <i>E. coli</i>, since our cultures always grow poorly when cI is expressed.
 +
 
 +
<br><br>
 +
<h7><p dir="ltr">We also wanted to study the function of various inducible and repressible promoters. One such promoter was the pLacI promoter. However, as you can see below, the RFP showed no change over the different concentrations of IPTG, suggesting something within the genetic circuit is broken. We are in the process of sequencing this circuit to see if we can determine if one of the BioBrick parts is incorrect.
 +
</ul></ul><br>
 +
<p>
 +
<center>
 +
<img src="https://static.igem.org/mediawiki/2012/2/23/PLac.png" width="300">
 +
<img src="https://static.igem.org/mediawiki/2012/2/29/PLac_cha.png" width="450">
 +
<br><br></p></center>
 +
 
 +
<ul><ul>
 +
<h7><p dir="ltr">Finally, we wanted to test some more basic BioBrick composite parts with the hope that we would be comparing this data directly with MoClo Level 1 parts. Despite lacking these Level 1 parts, we still tested the BioBrick composite parts. These more basic parts consisted of J231XX promoters controlling GFP (BBa_E0040) or RFP (BBa_E1010). They all had the BBa_B0034 RBS and BBa_B0015 terminator. We noticed that one of the promoters showed a large difference in expression of RFP and GFP (shown in bottom graph) despite the circuits having the same RBS. This suggests that the Anderson library promoters may not function the same when controlling different genes.
 +
<br><br>
 +
</ul></ul>
 +
<p>
 +
<center>
 +
<img src="https://static.igem.org/mediawiki/2012/e/ec/GFP_bu.png" width="250">
 +
<img src="https://static.igem.org/mediawiki/2012/6/68/RFP_bu.png" width="250">
 +
<br><br>
 +
</center>
 +
</p>
 +
 
 +
<p><center>
 +
<img src="https://static.igem.org/mediawiki/2012/3/38/Fitcbu.png" width="500"><br>
 +
<img src="https://static.igem.org/mediawiki/2012/1/1c/Mcherrybu.png" width="500"><br>
 +
<img src="https://static.igem.org/mediawiki/2012/4/41/Comparisonbu.png" width="400">
 +
</p>
 +
</center>
 +
 
 +
<div id="mmoR">
 +
<ul>
 +
<h9>Characterizing New BioBrick Parts</h9>
 +
<br>
 +
<ul>
 +
<h8>A New Repressible System: Copper and <i>mmoR</i></8>
 +
<br><br>
 +
<ul>
 +
<h7><p dir="ltr">We are also introducing a new promoter and gene pair to iGEM that forms a copper-dependent repressible system. Since the library of metal sensitive promoters was relatively small on the Registry of Standard Biological Parts, we decided to investigate a metal-dependent system. We chose <i>mmoR</i> and a &sigma;<sup>54</sup> promoter associated with it from a bacterium called <i>Methylosinus trichosporium</i> OB3b. <i>mmoR</i> is a &sigma;<sup>54</sup>-dependent transcriptional activator.
 +
<br><br>
 +
It is unclear if the &sigma;<sup>54</sup> promoter will function in <i>E. coli</i> in the absence of <i>mmoR</i>. nBLAST results comparing the <i>mmoR</i> to the <i>E. coli</i> genomes available yielded very short hits, with the top hit showing matches for less than 200bp out of the possible 2070bp length of <i>mmoR</i>. However, the pBLAST hits showed stronger hits with other &sigma;<sup>54</sup>-dependent transcriptional activators found in <i>E. coli</i>. The top nBLAST and pBLAST hits are shown below. <br><br>
 +
</ul></ul></ul></h7>
 +
<p>
 +
<center>
 +
<img src="https://static.igem.org/mediawiki/2012/4/4b/Nblastbu.png" width="870">
 +
</center>
 +
</p>
 +
<br><br>
 +
<ul><ul><ul>
 +
<h7><p dir="ltr">To determine if the &sigma;<sup>54</sup> promoter will function without <i>mmoR</i> present in <i>E. coli</i>, we PCR amplified 395bp of the &sigma;<sup>54</sup> promoter and cloned the product into the pSB1C3 BioBrick backbone. We then placed the promoter in front of GFP, RFP, and YFP using standard BioBrick cloning. Based on colony color from our transformations, it does not appear that the &sigma;<sup>54</sup> promoter will function alone in <i>E. coli</i>. We will be running a flow cytometry experiment on these clones for the Jamboree and working towards building the larger circuit shown at the bottom of this section.
 +
<br>
 +
<p>
 +
<center>
 +
<img src="https://static.igem.org/mediawiki/2012/2/27/PSiggfp.png" width="600">
 +
</center></p>
 +
 
 +
<br>
 +
<h7><p dir="ltr">We also amplified the same region of the &sigma;<sup>54</sup> promoter using MoClo primers and cloned it into one of our Level 0 MoClo destination vector.
 +
<br><br>
 +
We've also cloned <i>mmoR</i> into pSB1C3 and are in the process of building the circuit shown below. We will have an update on our progress for the Jamboree.
 +
<p>
 +
<center>
 +
<img src="https://static.igem.org/mediawiki/2012/4/48/MmoR_gfp.png" width="450">
 +
</center>
 +
Our <i>mmoR</i> and &sigma;<sup>54</sup> promoter work was inspired by <a href="http://onlinelibrary.wiley.com/doi/10.1111/j.1574-6968.2009.01816.x/pdf">Scanlan et. al, 2009</a>.
 +
<br><br><br><br>
 +
 
 +
<h8>References</h8>
 +
<br>
 +
<h7>[1] J. Scanlan et al. "Involvement of MmoR and MmoG..." FEMS Microbiology 301(2). 2009.</h7>
 +
<br><br><br><br>
 +
</html>

Latest revision as of 18:21, 26 October 2012

BostonU iGEM Team: Welcome

   


Data Collected


    Sequencing Data for Converted MoClo Parts

      We sequenced all of our new MoClo parts to ensure the proper fusion sites were flanking the part sequence. Below is a list of all of the confirmed, sequenced parts, including our two BioBrick parts for mmoR and pMmoR.


    After the wiki freezed we kept working on converting Biobricks to Level 0 MoClo parts and creating Level 2 Destination vectors. Below is a list of all of the confirmed, sequenced new parts.





    Characterizing BioBrick Based Devices

      We began to work on our characterization workflow in September because we had originally planned to have MoClo Level 1 and Level 2 parts to test by then. Unfortunately, due to many technical challenges, we do not have a Level 1 or Level 2 part to test yet. In order to move forward with our characterization thrust, we decided to test devices that had been made in our lab using BioBricks so we could begin to learn how to characterize devices using flow cytometry.

      One of those devices was an inverter under pBad (BBa_I13458-BBa_I13453) control. This inverter was built using the two-way BioBrick protocol and was submitted with the rest of our parts this year (BBa_K783067). As you can see below, this inverter functions as expected, where GFP increases with the addition of arabinose and thus the induction of the pBad promoter. The amount of RFP decreases as the amount of tetR increases, thus repressing the pTetR promoter.

      This inverter uses the RBS BBa_B0032 to drive the tetR gene, while the other two ribosomal binding sites are BBa_B0034. Previous work in our lab showed the use of BBa_B0034 to drive the tetR gene resulted in poor function for the inverter. By changing the RBS, the function of this inverter was improved.

   

 



      We also tried to test the function of a cI based inverter, where cI and pCI replace tetR and pTetR. Unfortunately, those cells grew poorly and we were unable to complete our experiment. We believe cI may have some level of toxicity to E. coli, since our cultures always grow poorly when cI is expressed.

      We also wanted to study the function of various inducible and repressible promoters. One such promoter was the pLacI promoter. However, as you can see below, the RFP showed no change over the different concentrations of IPTG, suggesting something within the genetic circuit is broken. We are in the process of sequencing this circuit to see if we can determine if one of the BioBrick parts is incorrect.




      Finally, we wanted to test some more basic BioBrick composite parts with the hope that we would be comparing this data directly with MoClo Level 1 parts. Despite lacking these Level 1 parts, we still tested the BioBrick composite parts. These more basic parts consisted of J231XX promoters controlling GFP (BBa_E0040) or RFP (BBa_E1010). They all had the BBa_B0034 RBS and BBa_B0015 terminator. We noticed that one of the promoters showed a large difference in expression of RFP and GFP (shown in bottom graph) despite the circuits having the same RBS. This suggests that the Anderson library promoters may not function the same when controlling different genes.





    Characterizing New BioBrick Parts
      A New Repressible System: Copper and mmoR

        We are also introducing a new promoter and gene pair to iGEM that forms a copper-dependent repressible system. Since the library of metal sensitive promoters was relatively small on the Registry of Standard Biological Parts, we decided to investigate a metal-dependent system. We chose mmoR and a σ54 promoter associated with it from a bacterium called Methylosinus trichosporium OB3b. mmoR is a σ54-dependent transcriptional activator.

        It is unclear if the σ54 promoter will function in E. coli in the absence of mmoR. nBLAST results comparing the mmoR to the E. coli genomes available yielded very short hits, with the top hit showing matches for less than 200bp out of the possible 2070bp length of mmoR. However, the pBLAST hits showed stronger hits with other σ54-dependent transcriptional activators found in E. coli. The top nBLAST and pBLAST hits are shown below.



        To determine if the σ54 promoter will function without mmoR present in E. coli, we PCR amplified 395bp of the σ54 promoter and cloned the product into the pSB1C3 BioBrick backbone. We then placed the promoter in front of GFP, RFP, and YFP using standard BioBrick cloning. Based on colony color from our transformations, it does not appear that the σ54 promoter will function alone in E. coli. We will be running a flow cytometry experiment on these clones for the Jamboree and working towards building the larger circuit shown at the bottom of this section.


        We also amplified the same region of the σ54 promoter using MoClo primers and cloned it into one of our Level 0 MoClo destination vector.

        We've also cloned mmoR into pSB1C3 and are in the process of building the circuit shown below. We will have an update on our progress for the Jamboree.

        Our mmoR and σ54 promoter work was inspired by Scanlan et. al, 2009.



        References
        [1] J. Scanlan et al. "Involvement of MmoR and MmoG..." FEMS Microbiology 301(2). 2009.



        Retrieved from "http://2012.igem.org/Team:BostonU/Data"